Home Medical OncologyQuestion

Would you use neoadjuvant CDK4/6 inhibitor and AI in HR+ breast cancer based upon the randomized phase II CORALLEEN trial?

1 Answers

Mednet Member

Medical Oncology · Cedars-Sinai Medical Center

I would not use CDK inhibitors in the neoadjuvant setting.

Register or Sign In to see full answer